Legend Biotech Corp LEGN
- LB1908 — Gastric Cancer Phase 1
- LB1908 — Esophageal Cancer Phase 1
- LB1908 — Pancreatic Cancer Phase 1
Claudin 18.2 (3 companies · 6 programs)
Companies with an active program directed at Claudin 18.2.
Allogene Therapeutics, Inc. ALLO
- ALLO-182 — Gastric Cancer
- ALLO-182 — Pancreatic Cancer
NovaBridge Biosciences NBP
- givastomig — Gastric Cancer Phase 2